Intrinsic Value of S&P & Nasdaq Contact Us

NanoViricides, Inc. NNVC NYSE

NYSE • Healthcare • Biotechnology • US • USD

SharesGrow Score
44/100
2/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

NanoViricides, Inc. (NNVC) has a negative trailing P/E of -2.5, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. Trailing earnings yield is -39.72%.

Criteria proven by this page:

  • VALUE (0/100, Fail) — negative P/E indicates the company is currently operating at a loss — DCF and P/E-based valuation models cannot produce meaningful results for unprofitable companies (P/E -2.5); trailing earnings yield is below the 10-year Treasury yield (~4.3%), meaning bonds offer a better return (EY -39.72%).
  • Trailing Earnings Yield -39.72% — negative yield confirms the company is currently unprofitable. Investors are paying for a turnaround rather than current earnings.

Overall SharesGrow Score: 41/100 with 2/7 criteria passed.

SharesGrow 7-Criteria Score
44/100
SG Score
View full scorecard →
VALUE
N/A
No coverage
FUTURE
100/100
Analyst consensus
→ Forecast
PAST
0/100
→ Income
HEALTH
75/100
Debt-to-Equity & liquidity
→ Health
MOAT
28/100
→ Income
GROWTH
15/100
→ Income
INCOME
N/A
No coverage

Valuation Snapshot — NNVC

Valuation Multiples
P/E (TTM)-2.5
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio0.00
EV/EBITDA667,804.1
Per Share Data
EPS (TTM)$-0.42
Book Value / Share$557,769.02
Revenue / Share$0.00
FCF / Share$-187,800.09
Yields & Fair Value
Earnings Yield-39.72%
Dividend Yield0.00%

Historical Valuation

Year P/E (TTM) PEG Ratio P/B Ratio P/S Ratio Dividend Yield
2016 -8.6 -0.02 4.00 0.00 -
2017 -7.9 1.01 3.99 0.00 -
2018 -3.3 0.14 1.62 0.00 -
2019 -2.1 0.16 1.61 0.00 -
2020 -3.1 -0.80 1.93 0.00 -
2021 -5.7 0.09 1.69 0.00 -
2022 -2.7 0.20 0.94 0.00 -
2023 -1.6 -0.27 0.90 0.00 -
2024 -2.6 0.49 1.92 0.00 -
2025 -2.2 0.22 2.82 0.00 -

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2016 $-3.72 $0.00 $-10.72M -
2017 $-3.43 $0.00 $-10.3M -
2018 $-2.64 $0.00 $-8.56M -
2019 $-2.30 $0.00 $-8.24M -
2020 $-2.39 $0.00 $-13.4M -
2021 $-0.82 $0.00 $-8.91M -
2022 $-0.70 $0.00 $-8.1M -
2023 $-0.74 $0.00 $-8.59M -
2024 $-0.70 $0.00 $-8.29M -
2025 $-0.63 $0.00 $-9.47M -

Analyst Estimates

Year EPS (Avg) EPS Range Revenue (Avg) Revenue Range Analysts
2026 $-0.35 $-0.35 – $-0.35 $3M $3M – $3M 1
2027 $-0.35 $-0.35 – $-0.35 $7M $7M – $7M 1
2028 $-0.35 $-0.35 – $-0.35 $0.00 $0.00 – $0.00 1
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message